A Phase II Study of Oxaliplatin, Dose-intense Capecitabine, and High-dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer
- Resource Type
- Short Communication
- Source
- In
Clinical Colorectal Cancer 2011 10(3):210-216 - Subject
- Language
- ISSN
- 1533-0028